Aducanumab: A Deep Dive into BIIB037 and its Impact The drug, previously known as BIIB037, constitutes a complex attempt to treat emerging Alzheimer's illness. Designed by Biogen, aducanumab functions by clearing https://www.targetmol.com/compound/aducanumab